This topic contains a solution. Click here to go to the answer

Author Question: A hidden cost fallacy can be avoided a. by ignoring the opportunity costs to using a capital b. by ... (Read 102 times)

beccaep

  • Hero Member
  • *****
  • Posts: 535
A hidden cost fallacy can be avoided
 a. by ignoring the opportunity costs to using a capital
 b. by ignoring the cost of capital
 c. by taking all capital costs into account including the cost of equity
 d. none of the above

Question 2

On average, if demand is unknown and costs of underpricing are _______ than the costs of overpricing, then err on the side of_________.
 a. Smaller; overpricing
 b. Smaller; underpricing
 c. Larger; underpricing
 d. None of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tjayeee

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

c

Answer to Question 2

b




beccaep

  • Member
  • Posts: 535
Reply 2 on: Jul 1, 2018
Gracias!


Viet Thy

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Excellent

 

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Pregnant women usually experience a heightened sense of smell beginning late in the first trimester. Some experts call this the body's way of protecting a pregnant woman from foods that are unsafe for the fetus.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library